Formuepleje A/S’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-127,467
| Closed | -$9.34M | – | 72 |
|
|
2024
Q1 | $9.34M | Buy |
127,467
+29,730
| +30% | +$2.29M | 0.53% | 52 |
|
|
2023
Q4 | $7.92M | Buy |
97,737
+428
| +0.4% | +$33.3K | 0.56% | 54 |
|
|
2023
Q3 | $7.29M | Buy |
97,309
+5,448
| +6% | +$419K | 0.68% | 47 |
|
|
2023
Q2 | $7.08M | Sell |
91,861
-13,093
| -12% | -$1.04M | 0.62% | 51 |
|
|
2023
Q1 | $8.71M | Buy |
104,954
+7,256
| +7% | +$601K | 0.64% | 47 |
|
|
2022
Q4 | $8.39M | Buy |
97,698
+46,011
| +89% | +$3.64M | 0.71% | 39 |
|
|
2022
Q3 | $3.19M | Buy |
+51,687
| New | +$3.26M | 0.26% | 73 |
|
|
2020
Q1 | – | Sell |
-603,857
| Closed | -$39.2M | – | 81 |
|
|
2019
Q4 | $39.2M | Buy |
603,857
+15,536
| +3% | +$1.01M | 2.53% | 16 |
|
|
2019
Q3 | $37.3M | Buy |
588,321
+5,449
| +0.9% | +$356K | 2.74% | 17 |
|
|
2019
Q2 | $39.4M | Buy |
582,872
+57,074
| +11% | +$3.75M | 3.06% | 13 |
|
|
2019
Q1 | $34.2M | Buy |
525,798
+34,556
| +7% | +$2.3M | 3.04% | 12 |
|
|
2018
Q4 | $30.7M | Buy |
491,242
+57,421
| +13% | +$4.01M | 3.38% | 11 |
|
|
2018
Q3 | $33.5M | Hold |
433,821
| – | – | 3.22% | 11 |
|
|
2018
Q2 | $30.7M | Buy |
433,821
+125,500
| +41% | +$8.86M | 3.25% | 12 |
|
|
2018
Q1 | $23.2M | Sell |
308,321
-150,300
| -33% | -$11.9M | 2.74% | 13 |
|
|
2017
Q4 | $32.9M | Buy |
458,621
+43,407
| +10% | +$3.3M | 3.37% | 12 |
|
|
2017
Q3 | $33.6M | Sell |
415,214
-117,665
| -22% | -$9M | 3.7% | 10 |
|
|
2017
Q2 | $37.7M | Buy |
532,879
+79,400
| +18% | +$5.28M | 3.93% | 9 |
|
|
2017
Q1 | $30.8M | Buy |
453,479
+15,200
| +3% | +$1.07M | 3.68% | 11 |
|
|
2016
Q4 | $31.4M | Buy |
438,279
+33,200
| +8% | +$2.47M | 4.12% | 8 |
|
|
2016
Q3 | $32M | Buy |
405,079
+55,100
| +16% | +$4.48M | 4.33% | 6 |
|
|
2016
Q2 | $29.2M | Buy |
349,979
+700
| +0.2% | +$62.1K | 3.99% | 8 |
|
|
2016
Q1 | $32.1M | Sell |
349,279
-1,800
| -0.5% | -$162K | 4.02% | 9 |
|
|
2015
Q4 | $35.5M | Sell |
351,079
-18,000
| -5% | -$1.87M | 4.04% | 8 |
|
|
2015
Q3 | $36.2M | Buy |
369,079
+126,610
| +52% | +$14.1M | 4.42% | 7 |
|
|
2015
Q2 | $28.4M | Sell |
242,469
-24,010
| -9% | -$2.62M | 3.34% | 11 |
|
|
2015
Q1 | $26.1M | Buy |
266,479
+112,842
| +73% | +$11.5M | 3.09% | 14 |
|
|
2014
Q4 | $14.5M | Buy |
153,637
+12,250
| +9% | +$1.27M | 1.85% | 18 |
|
|
2014
Q3 | $15.1M | Sell |
141,387
-259,780
| -65% | -$25.4M | 1.97% | 19 |
|
|
2014
Q2 | $33.3M | Buy |
+401,167
| New | +$31.2M | 3.34% | 12 |
|
Other funds holding GILD
Formuepleje A/S's GILD Position: Q2 2024 in Review
Formuepleje A/S sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 127,467 shares — an estimated $9.34M sold.
Formuepleje A/S first reported a position in GILD in Q2 2014 and held it in 30 quarters. The position peaked at $39.4M in Q2 2019. 1,681 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- Formuepleje A/S reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
- Formuepleje A/S sold 127,467 Gilead Sciences shares in Q2 2024, an estimated $9.34M.
- Formuepleje A/S first reported a position in Gilead Sciences in Q2 2014 and held it in 30 quarters.
- Formuepleje A/S's Gilead Sciences position peaked at $39.4M in Q2 2019.
- 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on Formuepleje A/S's 13F filing for Q2 2024, filed 27 Aug 2026.